Cytek Biosciences reports preliminary Q4 revenue of $62 million
Go back to Cytek Biosciences reports preliminary Q4 revenue of $62 million| (NASDAQ: CTKB) | Delayed: 4.44 -0.37 (7.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.81 | 52 Week High | $ | |||
| Open | $4.80 | 52 Week Low | $ | |||
| Day High | $4.84 | P/E | N/A | |||
| Day Low | $4.29 | EPS | $ | |||
| Volume | 943,483 | |||||

